发帖
雷达卡
<P><FONT size=5>03.27 18页</FONT></P>
<P> </P>
<P>
103692.pdf
(403.04 KB, 需要: 3 个论坛币)
<P>正文目录<BR>基因重组蛋白药物——原理、市场、发展方向...............................................................1<BR>一、重组蛋白药物生产原理......................................................................................1<BR>二、重组蛋白药物市场..............................................................................................2<BR>三、重组蛋白药物发展方向......................................................................................2<BR>重点公司推荐之双鹭药业（002038） ..............................................................................3<BR>一、基本情况..............................................................................................................3<BR>二、股权结构合理，管理层与股东利益一致化.......................................................3<BR>三、最突出的研发优势在于“上下游垂直一体化”...............................................4<BR>四、“近”看产品，“远”看发展模式.....................................................................5<BR>五、在保持内生性增长的同时，尝试进行外延扩张...............................................7<BR>六、分享企业的快速成长，维持“推荐”评级.......................................................8<BR>七、风险提示..............................................................................................................8<BR>重点公司推荐之通化东宝（600867） ..............................................................................9<BR>一、基本情况..............................................................................................................9<BR>二、谈谈胰岛素........................................................................................................10<BR>三、长期“推荐”评级............................................................................................14<BR>四、主要风险............................................................................................................14</P>
京公网安备 11010802022788号
